Patrick G Enright's Net Worth

$1.94 Billion

Estimate Recalculated Feb 28, 2024 06:44PM EST

Who is Patrick G Enright?

Patrick G Enright has an estimated net worth of $1.94 Billion. This is based on reported shares across multiple companies, which include VALENTIS INC, Inozyme Pharma, Inc., Lexeo Therapeutics, Inc., Axonics Modulation Technologies, Inc., Vera Therapeutics, Inc., RAPID MICRO BIOSYSTEMS, INC., CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, Jazz Pharmaceuticals plc, Esperion Therapeutics, Inc., Tricida, Inc., Talaris Therapeutics, Inc., Sierra Oncology, Inc., Vaxcyte, Inc., 89bio, Inc., Eargo, Inc., Kala Pharmaceuticals, Inc., Venus Concept Inc., Molecular Templates, Inc., Aptinyx Inc., Aimmune Therapeutics, Inc., and SEQUENOM INC.

SEC CIK

Patrick G Enright's CIK is 0001253886

Past Insider Trading and Trends

2020 was Patrick G Enright's most active year for acquiring shares with 29 total transactions. Patrick G Enright's most active month to acquire stocks was the month of April. 2015 was Patrick G Enright's most active year for disposing of shares, totalling 130 transactions. Patrick G Enright's most active month to dispose stocks was the month of February. 2023 saw Patrick G Enright paying a total of $16,999,990.00 for 4,304,460 shares, this is the most they've acquired in one year. In 2014 Patrick G Enright cashed out on 2,800,925 shares for a total of $111,949,611.98, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VALENTIS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Dec 2
Form 4
0
0
Mar 8
Form 4
0
0
Dec 3
No matching records found

Inozyme Pharma, Inc. (INZY) Snapshot price: $5.395

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+48.06%
1.35M
$3.69
$4,999,950.00
4.17M
Apr 19
Form 4
2.82M
$16.00
2.82M
Jul 28
Form 3
0
0
No matching records found

Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.57M
$11.00
2.57M
Nov 7
Form 3
0
0
No matching records found

Axonics Modulation Technologies, Inc. (AXNX) Snapshot price: $67.78

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.93M
$15.00
2.93M
Nov 2
Form 3
0
0
No matching records found

Vera Therapeutics, Inc. (VERA) Snapshot price: $37.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 10
Form 4
1.71M
$7.00
$11,999,995.00
1.71M
Feb 6
Form 4
0
0
May 24
Form 4
+10.76%
333.33K
$15.00
$4,999,995.00
3.43M
Feb 10
Form 4
3.1M
$11.00
3.1M
May 18
Form 4
0
0
May 13
Form 3
0
0
No matching records found